As an open access journal, Chronobiology in Medicine (CIM) will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).

Table of Contents

• 1. Website
• 2. Name of Journal
• 3. Peer Review Process
• 4. Ownership and Management
• 5. Governing Body
• 6. Editorial Team and Contact Information
• 7. Copyright and Licensing
• 8. Author Fees
• 9. Process for Identification of and Dealing with Allegations of Research Misconduct
• 10. Research & Publication Ethics
• 11. Publishing Schedule
• 12. Access
• 13. Archiving
• 14. Revenue Sources
• 15. Advertising
• 16. Direct Marketing

1. Website

The URL of official journal web site is https://www.chronobiologyinmedicine.org.

The CIM website proves that it is committed to high ethical and professional standards. It does not contain erroneous information, including any attempt to mimic another journal/publisher’s website.

Aims and scope: CIM publishes research articles dealing with the circadian rhythms in various medical fields and clinical sleep medicine. The Chronobiology in Medicine covers various biological rhythm studies, including sleep and wakefulness, in various medical areas, basic sciences and social sciences. Topics on the clinical sleep disorders such as sleep disordered breathing and insomnia influencing on the circadian rhythm disturbances will be considered for publication.

Readership: CIM is primarily for physicians, psychiatrists, neurologists, sleep medicine specialists, basic scientists and social scientists.

Authorship criteria: All persons designated as authors should qualify for authorship. Each author should have participated sufficiently in the work to take public responsibility for the content. According to criteria formulated by the International Committee of Medical Journal Editors (ICMJE), authorship credit should be based on the following 4 criteria: 1) substantial contributions to conception and design or analysis and interpretation of data, AND 2) drafting the article or revising it critically for important intellectual content, AND 3) final approval of the version to be published; AND 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All these 4 conditions must be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. All other contributors who do not meet these criteria for authorship should be noted in the Acknowledgments section. CIM does not consider people thanked in the Acknowledgements or listed as members of a study group on whose behalf a paper is submitted to be authors. CIM does accept notice of equal contribution for the first author when the study was clearly performed by co-first authors. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. But after publication, CIM does not correct authorship unless a mistake has been made by the editorial staff. Copyright assignment must also be completed by every author.

Corresponding author(s): One of the authors should be designated to receive correspondence and proofs, and the appropriate address indicated. This author(s) must take primary responsibility for communication with the journal during the manuscript submission, peer-review, and publication process. The corresponding author typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and disclosures of relationships and activities are properly completed and reported, although these duties may be delegated to one or more co-authors. The corresponding author should be available throughout the submission and peer-review process to respond to editorial queries in a timely way, and should be available after publication to respond to critiques of the work and cooperate with any requests from the journal for data or additional information should questions about the paper arise after publication [https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html].

eISSN: 2635-9162

2. Name of Journal

The official journal title is Chronobiology in Medicine, the abbreviation of ISO is Chronobiol Med.

3. Peer Review Process

All papers, including those invited by the Editor, are subject to peer review. If a manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for Authors, it may be returned to the author immediately after receipt and without a review. A submitted manuscript will be acknowledged and assigned a manuscript number, which is to be used in all further correspondence. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool. Manuscripts are reviewed and given a priority based on their originality, importance of the findings, scientific merit and significance for the field, interest to readers, lucidity, and suitability for publication. Manuscripts with insufficient priority for publication are rejected promptly. Other manuscripts are sent to expert consultants for peer review. The journal uses a double-blind peer-review process such that the identities of both the reviewers and authors are kept confidential. The existence of a manuscript under review is not revealed to anyone other than peer reviewers and editorial staff. Peer reviewers are expected to maintain strict confidentiality. Reviewers are also expected to inform the Editor of any conflicts of interest, including any financial arrangements involving companies whose products (or competing products) are featured in the manuscripts they agree to review. Statistical editing may be done if the data needs professional statistical review by a statistician.
After review, the editorial board determines whether or not the manuscript is accepted for publication. Once rejected, the manuscript is not subject to further review. Once the manuscript is received by the editorial board, an e-mail confirmation will be sent to the author within seven days. The author will be notified of any delays due to evaluation difficulties. Authors may contact the editorial committee for the current review phase of the manuscript. The board will inform the author of the status of the review process.

4. Ownership and Management

This journal is owned by the publisher, the Korean Neurocritical Care Society (http://www.sleep.or.kr).

Management Team:

Journal Manager: Heon-Jeong Lee, Korea University, Korea

Manager of the Review Process: Sehyun Jeon, Samsung Medical Center, Korea

Manuscript Editor: Haeja Kim, iMiS Company, Korea

Layout Editor: Seyoun Kim, iMiS Company, Korea

Website and JATS XML File Producer: Minyoung Choi, M2community, Korea

5. Governing Body

The governing body is the journal's editorial board.

6. Editorial Team / Contact Information

The full names and affiliations of the Editorial Board are displayed on the About (Editorial Board) tab of journal homepage (https://www.chronobiologyinmedicine.org), and the contact information for the Editor and editorial office is on the About (Contact Us) tab.

7. Copyright and Licensing

The copyright of the whole content of papers published in the Journal belongs to the Korean Academy of Sleep Medicine and all authors should sign the copyright transfer form after when their manuscript is submitted. CIM is an open access journal. Articles are published open access under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

8. Author Fees

There is no author-side submission fee or article processing charge. All publishing cost are supported by the Korean Academy of Sleep Medicine.

9. Process for Identification of and Dealing with Allegations of Research Misconduct

The CIM editorial board carefully examined all submitted manuscripts to determine whether they comply with the ethical guidelines of the ICMJE and COPE. Published articles cover conflict of interest declarations, the institutional review committee, informed consent, and human and animal rights. When the editorial board is faced with alleged instances of research and publication misconduct, such as duplication of publication, plagiarism, fabricated data, authoring changes, insiders and other issues, the resolution process will follow the flowchart provided by the COPE. (http://publicationethics.org/resources/flowcharts). The editorial board of CIM will discuss the suspected cases and reach a decision. CIM will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

10. Research & Publication Ethics

CIM aims to ensure that all articles published in the journal report on work that is morally acceptable, and expects authors to follow the World Medical Association’s Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). All of the manuscripts should be prepared in strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (CSE, https://www.councilscienceeditors.org/), International Committee of Medical Journal Editors (ICMJE, https://www.icmje.org/), World Association of Medical Editors (WAME, https://www.wame.org/), and the Korean Association of Medical Journal Editors (KAMJE, https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=).
Any study including human data must be reviewed and approved by a responsible Institutional Review Board (IRB). Animal experiments also should be reviewed by an appropriate committee (IACUC) for the care and use of animals. Also studies with pathogens requiring a high degree of biosafety should pass review of a relevant committee (IBC). The editor may request submission of copies of informed consents from human subjects in clinical studies or IRB approval documents. CIM will follow the guidelines by the Committee on Publication Ethics (COPE, https://publicationethics.org/) for settlement of any misconduct.

11. Publishing Schedule

CIM publishes quarterly (the last day of March, June, September and December).

12. Access

CIM is an open access journal. A free full-text service both in the XML and PDF formats is available immediately upon publication.

13. Archiving

Full text of CIM has been archived in National Library of Korea (https://www.nl.go.kr). Authors are permitted to self-archive the submitted version (preprint), accepted version (peer-reviewed), and publisher's version/PDF of the article at any time in their institutional repository or any non-profit repositories. CIM provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in National Library of Korea.

14. Revenues Sources

Revenue sources of journal are from the support of publisher (Korean Academy of Sleep Medicine).

15. Advertising

CIM does not accept any commercial product advertisements until policy changes otherwise.

16. Direct Marketing

The journal was distributed through the journal's website and through the distribution of an introductory brochure. Invitations to submit a manuscript are usually sent to presenters at conferences, seminars or workshops if the topic is related to the aims and scope of the journal.